Please login to the form below

Not currently logged in
Email:
Password:

Consilium wins Allergy Therapeutics account

Will advise the firm on international investor relations

Consilium Strategic CommunicationsConsilium Strategic Communications has been appointed by specialty pharmaceutical firm Allergy Therapeutics as its international investor relations advisor.

The healthcare agency will support Allergy Therapeutics' international financial and corporate public relations activities as it seeks to step up its international stakeholder activities.

Consilium's Mary-Jane Elliott, Chris Gardner, Ivar Milligan, Matthew Neal and Laura Thornton have been tasked with raising the European allergy product company's global profile, particularly focusing on the US.

Commenting on the Consilium advisory team, Allergy Therapeutics' chief executive officer Manuel Llobet said: “This team's expertise and knowledge of the sector is unrivalled and they have already demonstrated this through their high quality advice, proactivity and professionalism.”

Elliott, co-founder and managing partner at Consilium, said: “We are delighted to be advising Allergy Therapeutics at a time when they are on a steep growth trajectory due to a strong portfolio of marketed products and M&A.

“We look forward to accompanying them on their journey as they pave the way to the US market and further international growth.”

Article by
Rebecca Clifford

7th March 2016

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics